Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
The article presents an analysis of the therapeutic effect of the drug diacerein (D), which has been used in osteoarthritis (OA) for more than 20 years and is included in the clinical guidelines of the Association of Rheumatologists of Russia (2021) and the European Society for Clinical and Economic...
Main Authors: | I. B. Belyaeva, V. I. Mazurov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-08-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1329 |
Similar Items
-
Analysis of the therapeutic benefits of symptomatic slow acting drugs in osteoarthritis: emphasis on structural-modifying action
by: I. B. Belyaeva, et al.
Published: (2021-12-01) -
Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01) -
Tulovishchnoe ozhirenie i insulinrezistentnost' ? klyuchevoe zveno metabolicheskogo serdechno-sosudistogo sindroma
by: Ya V Blagosklonnaya, et al.
Published: (2003-03-01) -
Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01) -
Therapeutic potential of a drug based on avocado and soy unsaponifiable compounds in the treatment of osteoarthritis: data from Russian and international studies (descriptive review)
by: A. E. Karateev, et al.
Published: (2022-05-01)